Clevidence Information

Clevidence is a European health economics and market access consultancy dedicated to delivering evidence-based solutions that support informed healthcare decision-making. We specialize in Health Technology Assessment (HTA), Health Economics and Outcomes Research (HEOR), Market Access, Pricing & Reimbursement, Evidence Generation, and Real-World Evidence (RWE). We partner with pharmaceutical, biotechnology, medical device and healthcare organizations to generate robust clinical and economic evidence that demonstrates the value of health technologies throughout their lifecycle. Our multidisciplinary team provides high-quality consulting services across Systematic Literature Reviews (SLR), Network Meta-Analysis (NMA), Economic Modelling, Cost-Effectiveness Analysis (CEA), Budget Impact Analysis (BIA), Health Economic Evaluation, Value Dossiers, HTA submissions, and Post-Marketing Research. With extensive experience across European healthcare systems, we help clients navigate complex reimbursement pathways, optimize market access strategies, and support evidence-based healthcare policy through rigorous scientific research and data-driven insights. At Clevidence, we combine scientific excellence with practical expertise to deliver clear evidence for better healthcare decisions.